Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Asker Healthcare Group AB ( (SE:ASKER) ) just unveiled an update.
Asker Healthcare Group will release its Year-End Report for 2025 on 10 February at 08:10 CET and will host a webcast presentation the same day at 10:00 CET for investors, analysts and media. CEO Johan Falk and CFO Thomas Moss will present and comment on the results, followed by a Q&A session, with presentation materials and an on-demand replay to be made available on the company’s website, underscoring Asker’s efforts to maintain transparent communication with the capital market and other stakeholders.
The most recent analyst rating on (SE:ASKER) stock is a Buy with a SEK90.00 price target. To see the full list of analyst forecasts on Asker Healthcare Group AB stock, see the SE:ASKER Stock Forecast page.
More about Asker Healthcare Group AB
Asker Healthcare Group is a European healthcare group that partners with caregivers and patients across Europe by providing medical products and solutions. The company builds and acquires leading local healthcare suppliers to improve patient outcomes, reduce the total cost of care and promote a fair, sustainable value chain, leveraging the entrepreneurial drive of local companies with the scale and expertise of a larger group. Asker has more than 4,500 employees in 19 countries and generates revenues of about SEK 16 billion.
Average Trading Volume: 536,211
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK29.55B
For a thorough assessment of ASKER stock, go to TipRanks’ Stock Analysis page.